IPOX 100 U.S. closes above key 3,000 mark
Ahead of U.S. Options expiration, gains in high-beta exposure drive the IPXO 100 U.S. (IPXO) to a 10th consecutive day of gains, rising to +8.44% YTD, +16.39% above the Dec. 24., 2018 low.
Thursday’s strengths propelled the index back above key 3000 level.
IPOX component Internet infrastructure provider Twilio (TWLO US) and IPO M&A drug maker Eli Lilly (LLY) hit all-time highs.
Investment products linked to the IPOX 100 U.S. (IPXO) include the 5-star (10-year), USD billion 1 “FPX” ETF.
The IPOX 100 U.S. -linked “FPX” ETF provides FANG-free, large-cap growth & innovation centric exposure to 100 U.S. IPOs, Spin-offs and respective U.S. IPO & Spin-off M&A.